Search clinical trials for: coadministration of JP-1366 and meloxicam

Total 1900 results

Onconic Therapeutics Inc.

Completed

Compare Pharmacokinetics and Safety of JP-1366 Between Korean and Caucasian

Anti-Ulcer Agents

Korea, Republic of
Jeil Pharmaceutical Co., Ltd.

Completed

Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of JP-1366 Oral Administration in Healthy Male Subjects

Anti-Ulcer Agents

Korea, Republic of
Onconic Therapeutics Inc.

Completed

Clinical Trial to Evaluate the Safety and Efficacy of JP-1366 in Patients With Erosive Gastroesophageal Reflux Disease

GERD

Korea, Republic of
Onconic Therapeutics Inc.

Recruiting

JP-1366 20mg Versus Esomeprazole 40mg in Patients With Erosive Esophagitis

Erosive Esophagitis

Korea, Republic of
Onconic Therapeutics Inc.

Not yet recruiting

Clinical Trial to Evaluate the Efficacy and Safety of JP-1366 in Patients With Gastric Ulcer

Gastric Ulcer
Onconic Therapeutics Inc.

Completed

Drug-drug Interactions and Safety Among JP-1366, Amoxicillin, and Clarithromycin in Healthy Volunteers

Helicobacter Pylori Associated Gastrointestinal Disease

Korea, Republic of
Boehringer Ingelheim

Completed

Efficacy and Safety of Meloxicam vs. Naproxen Sodium in Patients With Acute Non Bacterial Pharyngitis or Pharyngo-tonsillitis

Pharyngitis
Boehringer Ingelheim

Completed

Study to Compare the the Analgesic Efficacy and Tolerability of Meloxicam Versus Placebo and Ibuprofen in the Treatment of Pain After Surgery of the Third Molar

Pain
Boehringer Ingelheim

Completed

Efficacy and Safety Study of Meloxicam Versus Mefenamic Acid in Patients With Dysmenorrhea

Dysmenorrhea
Boehringer Ingelheim

Completed

Study to Assess the Effect of Food on the Pharmacokinetics of Meloxicam After Single Administration and to Investigate Dose-proportionality Over a Dosage Range

Healthy
Boehringer Ingelheim

Completed

Bioequivalence Study of Meloxicam Capsules 15 mg (Mobic® Capsules 15 mg) Versus Meloxicam Tablets 15 mg (Mobic® Tablets 15 mg) in Healthy Adult Volunteers

Healthy
Boehringer Ingelheim

Completed

Effect of Food on the Pharmacokinetics of Meloxicam in Healthy Volunteers

Healthy
Boehringer Ingelheim

Completed

Pharmacokinetics and Tolerability of Meloxicam Gel Compared to Meloxicam Tablets in Healthy Subjects

Healthy
Boehringer Ingelheim

Completed

A Study to Compare Meloxicam IM Once Daily Versus Meloxicam Orally Once Daily in Patients With Rheumatoid Arthritis

Arthritis, Rheumatoid

China
Boehringer Ingelheim

Completed

Effect of Meloxicam Tablets on Bleeding Time in Healthy Subjects

Healthy
Boehringer Ingelheim

Completed

A Study to Compare Meloxicam IM Once Daily and Meloxicam Administered Orally Once Daily in Patients With Osteoarthritis

Osteoarthritis

China
Iroko Pharmaceuticals, LLC

Withdrawn

Meloxicam SoluMatrix® Capsules vs Meloxicam Tablets to Treat Osteoarthritis Pain

Osteoarthritis
Laboratorios Andromaco S.A.
Instituto Chileno de Medicina Reproductiva

Completed

Assessment of a Vaginal Ring With Meloxicam on Ovarian Cycle in Fertile Women

Contraception | Bleeding Pattern

Chile
Boehringer Ingelheim

Completed

Pharmacokinetics and Tolerability of Meloxicam Injected Intramuscularly vs. Tablet in Healthy Subjects

Healthy
Beijing Tide Pharmaceutical Co., Ltd
The Third Xiangya Hospital of Central South University

Not yet recruiting

Efficacy, Safety and Tolerability Study of Meloxicam Injection in Subjects After Abdominal Surgery

Pain, Post-operative

China
Boehringer Ingelheim

Completed

A Study to Compare the Amount of Meloxicam in the Blood When it is Taken as Capsules or as Tablets

Healthy

Russian Federation
Boehringer Ingelheim

Completed

Evaluation of Efficacy and Safety of Meloxicam Suppository (15mg Daily) and Tablet (15 mg Daily) Compared to Indomethacin Suppository (50 mg Daily) in Patients With Ankylosing Spondylitis

Spondylitis, Ankylosing
Syros Pharmaceuticals

Terminated

A Study of SY-1365 in Adult Patients With Advanced Solid Tumors

Breast Cancer | Ovarian Cancer | Advanced Solid Tumors

United States, Canada, France
Boehringer Ingelheim

Completed

A One Year Double-blind Trial to Investigate the Efficacy and Safety of Meloxicam Oral Suspension in Juvenile Rheumatoid Arthritis (JRA/JIA)

Arthritis, Juvenile Rheumatoid

Belgium, Italy, Germany, Russian Federation, France, Austria, United Kingdom
Boehringer Ingelheim

Completed

Relative Bioavailability of 1 mg and 10 mg BI 1356 BS as Powder in the Bottle (PIB) to 1 mg and 10 mg BI 1356 BS as Tablets as Single Oral Administration in Healthy Male Volunteers Including the Influence of Food on the Bioavailability of 10 mg BI 1356 BS

Healthy
Baudax Bio

Terminated

Safety and Pharmacokinetics of N1539 in Children 2 to <17 Years of Age Following Surgery

Post Operative Pain

United States
Massachusetts General Hospital
The Leukemia and Lymphoma Society

Completed

Meloxicam vs Placebo for Mobilization

Multiple Myeloma | Hodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Hematopoietic Stem Cells

United States
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Completed

Efficacy and Safety Study of Meloxicam Nanocrystal Injection for the Treatment of Moderate to Severe Pain

Pain

China
Iroko Pharmaceuticals, LLC

Completed

Study of Meloxicam Capsules in Subjects With Osteoarthritis of the Knee or Hip

Osteoarthritis

United States
Eurofarma Laboratorios S.A.

Withdrawn

A Parallel-group Active Comparator, Double-blind, Multicenter, Randomized, Double-blind, Phase III Clinical Study (SAVE)

Knee Osteoarthritis
Baudax Bio

Completed

Evaluation of Preoperative N1539 in Colorectal Surgery

Pain, Postoperative

United States
Baudax Bio

Completed

Placebo-Controlled Evaluation of N1539 Following Bunionectomy Surgery

Pain, Post-operative

United States
Boehringer Ingelheim

Completed

Safety and Efficacy of Linagliptin (BI 1356) Plus Metformin in Type 2 Diabetes, Factorial Design

Diabetes Mellitus, Type 2

Canada, Croatia, Estonia, France, Germany, India, Lithuania, Mexico, Netherlands, Romania, Russian Federation, Sweden, Tunisia, Ukraine
Boehringer Ingelheim

Completed

BI 1356 BS in Japanese Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2
Baudax Bio

Completed

Evaluation of N1539 Following Major Surgery

Pain, Post-operative

United States, Australia, New Zealand, Canada
GlaxoSmithKline

Completed

This Study is Randomised, Single Oral Dose Bioequivalence Study of Meloxicam GSK 15 MG Tablets. (BA/BE: 250/12)

Arthritis, Rheumatoid
Boehringer Ingelheim

Completed

Bioavailability of BI 1356 After Single Oral Administration Given as Different Tablet Formulation in Healthy Male Volunteers

Healthy
Solvay Pharmaceuticals

Completed

Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female Subjects

Atrial Fibrillation | Atrial Flutter

Russian Federation, Romania, United States, Argentina, Czech Republic, Former Serbia and Montenegro, Germany, Israel, Poland, Slovakia, South Africa, Ukraine, United Kingdom
VA Office of Research and Development

Completed

Discontinuing NSAIDs in Veterans With Knee Osteoarthritis

Knee Osteoarthritis

United States
Baudax Bio

Completed

Evaluation of N1539 Following Bunionectomy Surgery

Pain, Post-operative

United States
Boehringer Ingelheim

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 1356 BS as Tablet in Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2
Baudax Bio

Completed

Evaluation of N1539 Following Abdominoplasty Surgery

Pain, Post-operative

United States
Iroko Pharmaceuticals, LLC

Completed

Study of Meloxicam Capsules to Treat Osteoarthritis Pain

Osteoarthritis

United States
Boehringer Ingelheim

Completed

Influence of a High Fat Breakfast in the Pharmacokinetics of UH-AC62MU in Healthy Subjects

Healthy
Boehringer Ingelheim

Completed

Efficacy and Safety of 3 Doses of BI1356 (Linagliptin) in Type 2 Diabetes Patients

Diabetes Mellitus, Type 2

United States, Australia, Canada, Czech Republic, Russian Federation, Ukraine
Teva Pharmaceuticals USA

Completed

Meloxicam 15 mg Tablets Under Fasting Conditions

Healthy

Canada
Baudax Bio

Completed

Evaluation of Preoperative N1539 in Total Knee Arthroplasty

Pain, Postoperative

United States
University of Dundee
University of Nottingham; University of Glasgow

Completed

The Standard Care Versus Celecoxib Outcome Trial (SCOTLSSS)

Osteoarthritis | Rheumatoid Arthritis

United Kingdom, Denmark, Netherlands
Mylan Pharmaceuticals Inc

Completed

Food Study of Meloxicam Tablets 15 mg and Mobic® Tablets 15 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Meloxicam Tablets 15 mg and Mobic® Tablets 15 mg

Healthy

United States

3

Subscribe